Overview

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This is a retrospective, randomized, parallel, open-labeled, controlled study to find out whether STEMI patients undergoing emergency PCI can benefit from intensive atorvastatin treatment compared with routine treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Chao Yang Hospital
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium
Hydroxymethylglutaryl-CoA Reductase Inhibitors